311 related articles for article (PubMed ID: 26580879)
1. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet.
Saybel A; Artemenko A; Nikitin S; Kurenkov A
J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
[TBL] [Abstract][Full Text] [Related]
3. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of IncobotulinumtoxinA for the treatment of platysmal bands of the aging neck: an open-label, prospective pilot study.
Gubanova EI; Panova OS; Sanchez EA; Rodina MY; Starovatova PA
J Drugs Dermatol; 2013 Dec; 12(12):1461-6. PubMed ID: 24301249
[TBL] [Abstract][Full Text] [Related]
5. A prospective rater- and subject-blinded study comparing the efficacy of incobotulinumtoxinA and onabotulinumtoxinA to treat crow's feet: a clinical crossover evaluation.
Muti G; Harrington L
Dermatol Surg; 2015 Jan; 41 Suppl 1():S39-46. PubMed ID: 25548844
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
Ascher B; Rzany BJ; Grover R
Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet.
Lowe NJ; Ascher B; Heckmann M; Kumar C; Fraczek S; Eadie N;
Dermatol Surg; 2005 Mar; 31(3):257-62. PubMed ID: 15841623
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
[TBL] [Abstract][Full Text] [Related]
9. Different injection patterns of incobotulinumtoxinA for crow's feet: a split-face comparative study.
Vachiramon V; Subpayasarn U; Triyangkulsri K; Jurairattanaporn N; Rattananukrom T
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):256-262. PubMed ID: 33068445
[TBL] [Abstract][Full Text] [Related]
10. Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus Lines.
Soares DJ; Dejoseph LM; Zuliani GF; Liebertz DJ; Patel VS
Dermatol Surg; 2015 Jun; 41(6):712-7. PubMed ID: 25973563
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
Kerscher M; Rzany B; Prager W; Turnbull C; Trevidic P; Inglefield C
Dermatol Surg; 2015 Oct; 41(10):1149-57. PubMed ID: 26359996
[TBL] [Abstract][Full Text] [Related]
12. Does Increasing the Dose of Abobotulinumtoxina Impact the Duration of Effectiveness for the Treatment of Moderate to Severe Glabellar Lines?
Joseph JH; Eaton LL; Robinson J; Pontius A; Williams EF
J Drugs Dermatol; 2016 Dec; 15(12):1544-1549. PubMed ID: 29106437
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow's feet.
Guerrissi JO
Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):161S-163S. PubMed ID: 14504499
[No Abstract] [Full Text] [Related]
14. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
Fabi SG; Sundaram H; Guiha I; Goldman MP
J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
[TBL] [Abstract][Full Text] [Related]
15. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
Lowe NJ; Shah A; Lowe PL; Patnaik R
J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study.
Elridy AS; Zaki RGE; Elshinawy RF
Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides.
Kiripolsky MG; Goldman MP
J Cosmet Dermatol; 2011 Sep; 10(3):232-4. PubMed ID: 21896136
[TBL] [Abstract][Full Text] [Related]
18. Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA.
Yu KC; Nettar KD; Bapna S; Boscardin WJ; Maas CS
Arch Facial Plast Surg; 2012; 14(3):198-204. PubMed ID: 22183059
[TBL] [Abstract][Full Text] [Related]
19. A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles.
Yeilding RH; Fezza JP
Plast Reconstr Surg; 2015 May; 135(5):1328-1335. PubMed ID: 25919246
[TBL] [Abstract][Full Text] [Related]
20. Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
Kawashima M; Harii K; Horiuchi Y; Seidman E; Lei X; Hopfinger R; Lee E
Dermatol Surg; 2020 Apr; 46(4):483-490. PubMed ID: 31517663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
